[{"address1": "8 Moore Drive", "city": "Durham", "state": "NC", "zip": "27709", "country": "United States", "phone": "877 495 0816", "website": "https://www.fortrea.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Fortrea Holdings Inc., a contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide. It offers clinical services that provides development and consulting services to clinical pharmacology and clinical development spectrum. The company also offers delivery models that include full service, functional service provider, and hybrid service structures. In addition, it delivers phase I \u0096 IV clinical trial management, clinical pharmacology, and consulting services. Fortrea Holdings Inc. enters into a strategic collaboration with Emery Pharma to provide rapid lot-by-lot, 1-methyl-4-nitrosopiperazine (MNP) testing of rifampin, the preferred drug for drug-drug interaction studies, to certify impurities are below the Acceptable Intake Limit set by U.S. Food and Drug Administration guidelines. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.", "fullTimeEmployees": 15000, "companyOfficers": [{"maxAge": 1, "name": "Mr. Peter M. Neupert", "age": 68, "title": "Interim CEO, Chairman of the Board & Lead Independent Director", "yearBorn": 1956, "fiscalYear": 2024, "totalPay": 110000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jill  McConnell", "age": 49, "title": "Chief Financial Officer", "yearBorn": 1975, "fiscalYear": 2024, "totalPay": 521359, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mark A. Morais", "age": 47, "title": "COO & President of Clinical Services", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 517090, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Drayton  Virkler", "title": "President & Chief Commercial Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert  Parks", "title": "Chief Accounting Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Alejandro Martinez Galindo", "title": "Chief Information Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Dave  Cooper", "title": "Chief Administrative Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Hima B. Inguva", "title": "Head of Investor Relations & Corporate Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. J. Stillman Hanson J.D.", "title": "General Counsel & Corporate Secretary", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Oren J. Cohen M.D.", "age": 63, "title": "Chief Medical Officer & President of Clinical Pharmacology", "yearBorn": 1961, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 10, "boardRisk": 4, "compensationRisk": 4, "shareHolderRightsRisk": 5, "overallRisk": 5, "governanceEpochDate": 1754006400, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 5.74, "open": 5.96, "dayLow": 5.265, "dayHigh": 6.04, "regularMarketPreviousClose": 5.74, "regularMarketOpen": 5.96, "regularMarketDayLow": 5.265, "regularMarketDayHigh": 6.04, "payoutRatio": 0.0, "beta": 1.761, "forwardPE": 4.167939, "volume": 1494658, "regularMarketVolume": 1494658, "averageVolume": 2844320, "averageVolume10days": 1888600, "averageDailyVolume10Day": 1888600, "bid": 5.44, "ask": 5.48, "bidSize": 8, "askSize": 8, "marketCap": 494350048, "fiftyTwoWeekLow": 3.97, "fiftyTwoWeekHigh": 26.59, "priceToSalesTrailing12Months": 0.18407434, "fiftyDayAverage": 5.2039, "twoHundredDayAverage": 11.913425, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 1680029952, "profitMargins": -0.29431, "floatShares": 85353265, "sharesOutstanding": 90540304, "sharesShort": 14330561, "sharesShortPriorMonth": 14940500, "sharesShortPreviousMonthDate": 1749772800, "dateShortInterest": 1752537600, "sharesPercentSharesOut": 0.1583, "heldPercentInsiders": 0.0039500003, "heldPercentInstitutions": 0.98704004, "shortRatio": 5.47, "shortPercentOfFloat": 0.2408, "impliedSharesOutstanding": 95187696, "bookValue": 9.49, "priceToBook": 0.5753425, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -754600000, "trailingEps": -8.39, "forwardEps": 1.31, "enterpriseToRevenue": 0.626, "enterpriseToEbitda": -85.716, "52WeekChange": -0.7866354, "SandP52WeekChange": 0.20277917, "quoteType": "EQUITY", "currentPrice": 5.46, "targetHighPrice": 15.5, "targetLowPrice": 4.75, "targetMeanPrice": 6.65909, "targetMedianPrice": 5.0, "recommendationMean": 3.0, "recommendationKey": "hold", "numberOfAnalystOpinions": 11, "totalCash": 101600000, "totalCashPerShare": 1.123, "ebitda": -19600000, "totalDebt": 1287500032, "quickRatio": 0.831, "currentRatio": 0.971, "totalRevenue": 2685600000, "debtToEquity": 149.918, "revenuePerShare": 29.931, "returnOnAssets": -0.01741, "returnOnEquity": -0.61582, "grossProfits": 542800000, "freeCashflow": 310662496, "operatingCashflow": 164200000, "revenueGrowth": -0.016, "grossMargins": 0.20211, "ebitdaMargins": -0.0073, "operatingMargins": -0.03808, "financialCurrency": "USD", "symbol": "FTRE", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "shortName": "Fortrea Holdings Inc.", "longName": "Fortrea Holdings Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1686922200000, "postMarketChangePercent": 2.1978002, "postMarketPrice": 5.58, "postMarketChange": 0.119999886, "regularMarketChange": -0.28, "regularMarketDayRange": "5.265 - 6.04", "corporateActions": [], "postMarketTime": 1754091008, "regularMarketTime": 1754078401, "exchange": "NMS", "messageBoardId": "finmb_1793665465", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 2844320, "fiftyTwoWeekLowChange": 1.49, "fiftyTwoWeekLowChangePercent": 0.37531486, "fiftyTwoWeekRange": "3.97 - 26.59", "fiftyTwoWeekHighChange": -21.130001, "fiftyTwoWeekHighChangePercent": -0.7946597, "fiftyTwoWeekChangePercent": -78.66354, "earningsTimestamp": 1754483400, "earningsTimestampStart": 1754483400, "earningsTimestampEnd": 1754483400, "earningsCallTimestampStart": 1754481600, "earningsCallTimestampEnd": 1754481600, "isEarningsDateEstimate": false, "regularMarketChangePercent": -4.87804, "regularMarketPrice": 5.46, "epsTrailingTwelveMonths": -8.39, "epsForward": 1.31, "epsCurrentYear": 0.45508, "priceEpsCurrentYear": 11.99789, "fiftyDayAverageChange": 0.25610018, "fiftyDayAverageChangePercent": 0.049213126, "twoHundredDayAverageChange": -6.4534254, "twoHundredDayAverageChangePercent": -0.5416935, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Clinical Development business of Laboratory Corporation of America Holdings", "nameChangeDate": "2025-07-27", "averageAnalystRating": "3.0 - Hold", "cryptoTradeable": false, "displayName": "Fortrea", "trailingPegRatio": null, "__fetch_time": "2025-08-02"}]